PhaseRx Market Cap

PhaseRx has a market cap or net worth of $1.17 thousand as of July 1, 2025. Its market cap has decreased by -96.67% in one year.

Market Cap

1.17K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 1.17K, a decrease of -100.00%. That is a compound annual growth rate of -69.57%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2025	1.17K	-49.98%
Dec 31, 2021	2.34K	-92.59%
Dec 31, 2020	31.61K	285.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.62B
Veradigm	781.22M
Elite Pharmaceuticals	715.74M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	414.48M
Glass House Brands	405.91M
CytoDyn	398.21M

Market Cap Rankings